Citation Impact
Citing Papers
A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation
2002 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Diet and Lifestyle Recommendations Revision 2006
2006 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity
2007
Effectiveness of theophylline prophylaxis of renal impairment after coronary angiography in patients with chronic renal insufficiency
2003
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
2009 Standout
Prophylactic Oral Amiodarone for the Prevention of Arrhythmias That Begin Early After Revascularization, Valve Replacement, or Repair
2005
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
Acute kidney injury
2012 Standout
Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial
2007
Management of Patients Undergoing Percutaneous Coronary Revascularization
2003
Rhythm or rate control in atrial fibrillation—Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial
2000
An Acute Model for Atrial Fibrillation Arising from a Peripheral Atrial Site: Evidence for Primary and Secondary Triggers
2008
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
N-3 Fatty Acids for the Prevention of Atrial Fibrillation After Coronary Artery Bypass Surgery
2005 Standout
Systematic review of the impact of N-acetylcysteine on contrast nephropathy
2004
Quality of Life in Patients with Atrial Fibrillation: A Systematic Review
2006
A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: Lack of effect
2004
Long‐Term Outcome of Atrial Fibrillation Ablation: Impact and Predictors of Very Late Recurrence
2010
Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials
2003
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
Pharmacological Management of Atrial Fibrillation following Cardiac Surgery
2005
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Diseases
2009 Standout
Right and Left Atrial Radiofrequency Catheter Therapy of Paroxysmal Atrial Fibrillation
1996
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
2006 Standout
Prevention of Contrast-Induced AKI
2013
Acute kidney injury
2019 Standout
Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation
2003
Sodium Bicarbonate is Associated with an Increased Incidence of Contrast Nephropathy
2007
Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials
2004
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation
1996 Standout
Role of left atrial appendageobliteration in stroke reductionin patients with mitral valve prosthesis
2003
Prophylaxis Strategies for Contrast-Induced Nephropathy
2006
Pharmacologic prophylaxis for atrial fibrillation following cardiac surgery: a systematic review
2010
Nonchannel drug targets in atrial fibrillation
2004
A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial Fibrillation
2002 Standout
Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation
2001
Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter11A list of principal investigators appears in the Appendix.
1999
N-Acetylcysteine in the prevention of contrast-induced nephropathy: Publication bias perpetuated by meta-analyses
2007
Effect of N-acetylcysteine for prevention of contrast nephropathy in patients with moderate to severe renal insufficiency: a randomized trial
2004
Secondary prevention with folic acid: effects on clinical outcomes
2003
Acetylcysteine in the Prevention of Contrast-Induced Nephropathy
2006
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
2007 Standout
Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes
2009
Significant effects of atrioventricular node ablation and pacemaker implantation on left ventricular function and long-term survival in patients with atrial fibrillation and left ventricular dysfunction
2003
Meta-analysis of antiarrhythmic therapy in the prevention of postoperative atrial fibrillation and the effect on hospital length of stay, costs, cerebrovascular accidents, and mortality in patients undergoing cardiac surgery
2003
The role of osmolality in the incidence of contrast-induced nephropathy: A systematic review of angiographic contrast media in high risk patients
2005
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
Mitral valve surgery and atrial fibrillation: is atrial fibrillation surgery also needed?
2000
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Sotalol versus propafenone for long-term maintenance of normal sinus rhythm in patients with recurrent symptomatic atrial fibrillation
2004
Atrial Fibrillation
2001
Pharmacological Prevention of Atrial Tachycardia Induced Atrial Remodeling as a Potential Therapeutic Strategy
2003
Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins
1998 Standout
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Ascorbic Acid Prevents Contrast-Mediated Nephropathy in Patients With Renal Dysfunction Undergoing Coronary Angiography or Intervention
2004
Radiofrequency Catheter Ablation of the Atria Reduces Inducibility and Duration of Atrial Fibrillation in Dogs
1995
Mapping-guided ablation of pulmonary veins to cure atrial fibrillation
2000
Inflammation as a Risk Factor for Atrial Fibrillation
2003 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
Interventions on Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Heart Surgery
2002
Predictors of Systemic Embolism in Patients with Mitral Stenosis: A Prospective Study
1998
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery
2013
Guidelines for the Primary Prevention of Stroke
2014 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial.
2004
Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease
2006 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Mechano-Electrical Interaction Late After Fontan Operation
2004
Worldwide Epidemiology of Atrial Fibrillation
2013 Standout
Clinical Outcomes After Ablation and Pacing Therapy for Atrial Fibrillation
2000
Contrast-Induced Nephropathy
2006
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Meta-analysis: Effectiveness of Drugs for Preventing Contrast-Induced Nephropathy
2008
Effectiveness of N ‐Acetylcysteine for the Prevention of Contrast‐Induced Nephropathy: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
2016
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2006
Effect of Simvastatin and Antioxidant Vitamins on Atrial Fibrillation Promotion by Atrial-Tachycardia Remodeling in Dogs
2004
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
2009 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
2010 Standout
Works of Jun-Jack Cheng being referenced
Predictors of Early and Late Recurrence of Atrial Fibrillation after Catheter Ablation of Paroxysmal Atrial Fibrillation
2004
Reappraisal by transesophageal echocardiography of the significance of left atrial thrombi in the prediction of systemic arterial embolization in rheumatic mitral valve disease
1992
Predictors of Non-Pulmonary Vein Ectopic Beats Initiating Paroxysmal Atrial Fibrillation
2005
Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure
2002
The role of P wave in prediction of atrial fibrillation after coronary artery surgery
1999
Significance of left atrial spontaneous echo contrast in rheumatic mitral valve disease as a predictor of systemic arterial embolization: A transesophageal echocardiographic study
1994
Intravenous amiodarone for prevention of atrial fibrillation after coronary artery bypass grafting
2000
Comparisons of Oral Propafenone and Sotalol as an Initial Treatment in Patients With Symptomatic Paroxysmal Atrial Fibrillation
1997
Recovery of atrial function after atrial compartment operation for chronic atrial fibrillation in mitral valve disease
1994
Effect of Verapamil on Long-Term Tachycardia-Induced Atrial Electrical Remodeling
2000
Comparisons of Quality of Life and Cardiac Performance After Complete Atrioventricular Junction Ablation and Atrioventricular Junction Modification in Patients With Medically Refractory Atrial Fibrillation
1998